NACFC 2026 | W20: Emerging Concepts in Gastrointestinal and Hepatobiliary Disease in CF

1. Pancreatic Cysts Across the CFTR Disease Spectrum: Prevalence, Predictors, and Clinical Implications – Presented by Daniel Dong 2. Colon Cancer Screening in Cystic Fibrosis: Lessons Learned from a Multiphase Quality Improvement Project – Presented by Abigail Braun 3. PROBE-CF: Profiling Biomarkers of the Esophagus in Patients with Cystic Fibrosis Treated with Elexacaftor/Tezacaftor/Ivacaftor – Presented by Racha Khalaf 4. Pancreatic Cystosis or IPMN? Characterizing Cystic Pancreatic Lesions in Cystic Fibrosis – Presented by Carlie Aurubin 5. Body Composition and Clinical Implications in Adults With CF: Baseline Results of the STRONG-CF Study – Presented by Adam Stein Originally recorded Oct. 9, 2026.